Hudson Bay Capital Management
DAWN

Hudson Bay Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Hudson Bay Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-670,000
Closed -$14.4M – 1424
2026
Q1 		$14.4M Sell
670,000
-1,030,000
-61% -$14.5M 0.05% 242
2025
Q4 		$15.8M Buy
1,700,000
+380,000
+29% +$3.17M 0.05% 256
2025
Q3 		$9.31M Buy
1,320,000
+23,300
+2% +$160K 0.03% 375
2025
Q2 		$8.43M Buy
1,296,700
+146,300
+13% +$1.01M 0.03% 398
2025
Q1 		$9.12M Buy
1,150,400
+230,292
+25% +$2.48M 0.03% 425
2024
Q4 		$11.7M Buy
920,108
+200,000
+28% +$2.78M 0.04% 334
2024
Q3 		$10M Buy
720,108
+165,000
+30% +$2.35M 0.04% 288
2024
Q2 		$7.65M Buy
555,108
+445,108
+405% +$6.51M 0.04% 288
2024
Q1 		$1.82M Buy
110,000
+30,000
+38% +$449K 0.01% 470
2023
Q4 		$1.17M Buy
+80,000
New +$970K 0.01% 506

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hudson Bay Capital Management's DAWN Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 670,000 shares — an estimated $14.4M sold.

Hudson Bay Capital Management first reported a position in DAWN in Q4 2023 and held it in 10 quarters. The position peaked at $15.8M in Q4 2025. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 670,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $14.4M.
  • Hudson Bay Capital Management first reported a position in Day One Biopharmaceuticals in Q4 2023 and held it in 10 quarters.
  • Hudson Bay Capital Management's Day One Biopharmaceuticals position peaked at $15.8M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.